Naveau S, Poynard T, Abella A, Pignon J P, Poitrine A, Agostini H, Zourabichvili O, Chaput J C
Hepatology. 1985 Sep-Oct;5(5):819-23. doi: 10.1002/hep.1840050518.
The aim of this study was to assess prospectively the prognostic value of serum fibronectin in 114 alcoholic cirrhotic patients and to compare serum fibronectin with other prognostic variables. The Cox model and log-rank test were used to compare survival rates at 1 year. Considered alone, serum fibronectin, age, serum albumin, total serum bilirubin, gamma-glutamyl transpeptidase, prothrombin time, presence of encephalopathy and ascites were associated with survival to 1 year. The estimated survival rate at the end of 1 year was, for patients with serum fibronectin greater than 165 mg per liter: 84 +/- 5%, and for patients with serum fibronectin less than or equal to 165 mg per liter: 53 +/- 7% (p less than 0.001). With the step-wise multidimensional analysis using the Cox model to assess the combined effect of several prognostic variables, serum fibronectin was the first variable selected followed by age, encephalopathy and serum albumin which entered the model by virtue of their independent prognostic value. Multivariate regression and partial correlation analysis showed that fibronectin was independently correlated with serum albumin, gamma-glutamyl transpeptidase and total serum bilirubin explaining that the prognostic value of albumin diminished and that the prognostic value of total serum bilirubin and gamma-glutamyl transpeptidase disappeared when combined with serum fibronectin.
本研究的目的是前瞻性评估血清纤连蛋白在114例酒精性肝硬化患者中的预后价值,并将血清纤连蛋白与其他预后变量进行比较。采用Cox模型和对数秩检验比较1年时的生存率。单独考虑时,血清纤连蛋白、年龄、血清白蛋白、总血清胆红素、γ-谷氨酰转肽酶、凝血酶原时间、肝性脑病和腹水的存在与1年生存率相关。血清纤连蛋白大于165毫克/升的患者,1年末的估计生存率为:84±5%,血清纤连蛋白小于或等于165毫克/升的患者为:53±7%(p<0.001)。使用Cox模型进行逐步多维度分析以评估多个预后变量的联合效应时,血清纤连蛋白是首先入选的变量,其次是年龄、肝性脑病和血清白蛋白,它们凭借独立的预后价值进入模型。多变量回归和偏相关分析表明,纤连蛋白与血清白蛋白、γ-谷氨酰转肽酶和总血清胆红素独立相关,这解释了与血清纤连蛋白联合时白蛋白的预后价值降低,以及总血清胆红素和γ-谷氨酰转肽酶的预后价值消失。